The hemp cannabinoid market in Japan has experienced significant expansion from 2019 to 2023, with a sixfold increase to ¥24 billion (around $154 million), based on a recent report by Euromonitor International as reported in the Japan Times. This growth is mainly due to the rising demand for CBD products in the country.
Euromonitor International estimates that Japan currently has approximately 588,000 active CBD consumers. Despite the growing interest, Japan maintains strict laws that criminalize the possession and use of cannabis products with intoxicating effects.
In a noteworthy development in December, Japan’s parliament approved revisions to the Cannabis Control Law, marking the first step towards decriminalizing the use of medical products derived from cannabis. The updated law also addresses loopholes by explicitly prohibiting cannabis use.
Aya Suzuki, a senior analyst at Euromonitor International, shared insights with the Times, highlighting that leading companies like UHA Mikakuto and Cheerio have already introduced CBD-infused gummies and beverages in specific regions and sales channels. Suzuki mentioned the increasing diversification in product offerings, stating, “The primary method of CBD consumption remains liquid form (vapes), but we anticipate major corporations entering the market with CBD-infused food, drinks, and dietary supplements.”
Furthermore, Suzuki noted that it is common for Japanese businesses to import CBD product ingredients from abroad. However, some business owners have faced challenges with customs officials suspecting THC content in the imported goods, resulting in confiscations.
Related on Weedly: Keep exploring the Weedly Glossary, our strain reviews, the Learn hub, our Canada coverage and our USA coverage.
Sources & further reading: For authoritative background see Project CBD, Health Canada, NIDA (US National Institute on Drug Abuse), the World Health Organization and Wikipedia.
The context: Japan’s strict cannabis stance
To understand the significance of Japan’s growing hemp-derived cannabinoid market, it helps to know how strict the country’s overall cannabis stance is. Japan maintains some of the developed world’s toughest cannabis laws, with serious penalties for recreational cannabis and intense social stigma. Against that backdrop, the emergence of a booming legal market for hemp-derived cannabinoids and CBD is striking — a bounded, tightly regulated commercial opening within an otherwise prohibitionist framework. This tension between strict prohibition and a thriving legal cannabinoid niche is central to Japan’s evolving relationship with the cannabis plant, and it explains why market growth there draws attention.
Why the market grew
Japan’s hemp-derived cannabinoid and CBD market expanded rapidly because these products occupy a legal space distinct from prohibited cannabis. CBD and certain hemp-derived compounds, when compliant with Japan’s strict requirements — particularly around THC content — could be legally sold, opening a wellness market for oils, cosmetics, drinks and supplements. Rising consumer interest in CBD wellness, combined with the legality of compliant products, fueled explosive growth. The surge reflects both global CBD trends and Japan’s specific regulatory carve-out, demonstrating that demand for cannabinoid wellness products exists even in a country with strict cannabis laws.
The regulatory backdrop
Japan’s cannabinoid market operates under exacting rules. Products must generally be free of detectable THC and derived from permitted parts of the plant, and regulators have worked to clarify and sometimes tighten the framework. Japan also updated its broader cannabis laws to create a pathway for approved cannabis-derived medicines while reinforcing controls on use. This regulatory backdrop shapes what can be sold and how, and it means the market’s growth has occurred within carefully policed boundaries. Companies operating in the space must navigate strict compliance, and the rules can evolve, affecting which products remain legal.
What it means for the industry
The growth of Japan’s hemp cannabinoid market signals significant commercial opportunity within a challenging regulatory environment. For the cannabis and wellness industry, Japan represents a large consumer market where compliant CBD and hemp products can thrive even as recreational cannabis remains off-limits. This makes Japan an important, if specialized, market — one where success depends on strict adherence to THC-free and sourcing requirements. The surge underscores that regulated cannabinoid wellness can be a substantial business even in prohibitionist countries, a lesson relevant across Asia and beyond.
The wider Asian picture
Japan’s cannabinoid market fits into a broader Asian landscape where cannabis remains largely prohibited but selective openings — medical pathways, CBD markets — are emerging. While Thailand dramatically liberalized in 2022 before tightening again, most of Asia, including Japan, maintains strict recreational prohibition alongside narrow legal niches. Japan’s bounded CBD and hemp market exemplifies how even the strictest countries can host regulated cannabinoid commerce. This selective liberalization, within firm limits, is a recurring theme across the region and reflects cautious engagement with cannabis’s commercial and medical potential.
Learn more
For a fuller picture of how Japan approaches cannabis overall — including its strict laws, the extraterritorial reach of its rules, the recent medical pathway and the CBD exception — see our in-depth guide to Japan’s cannabis laws and the CBD exception. You can also explore the broader global picture on our International desk and learn key terms in the cannabis glossary. For authoritative background, see the overview of cannabis in Japan.
The global CBD boom reaches Japan
Japan’s cannabinoid surge is part of a worldwide CBD wellness boom that has swept across many countries in recent years. From the United States and Europe to Asia, CBD products marketed for relaxation, sleep and general wellness have become mainstream consumer goods. Japan’s participation in this trend — within its strict THC-free requirements — shows how global consumer demand for cannabinoid wellness transcends even the toughest cannabis regimes. The Japanese market’s rapid expansion mirrors patterns seen elsewhere, adapted to local rules, and positions Japan as a significant node in the global CBD economy despite its prohibition of recreational cannabis.
What to watch next
The key questions for Japan’s cannabinoid market are regulatory. As authorities refine the rules around hemp-derived compounds, THC thresholds and novel cannabinoids, the boundaries of what can be legally sold may shift, affecting the market’s trajectory. Japan’s parallel move to permit approved cannabis-derived medicines while tightening use rules adds another dimension. Businesses and consumers alike will watch how regulators balance commercial growth against Japan’s cautious drug-policy tradition. The market’s future depends less on demand — which is clearly strong — than on how the regulatory framework evolves in the years ahead.
The bottom line
Japan’s rapidly growing hemp-derived cannabinoid and CBD market is a striking development in one of the world’s strictest cannabis countries — a thriving, tightly regulated commercial niche within an otherwise prohibitionist framework. Driven by demand for CBD wellness products and enabled by a legal carve-out for compliant, THC-free items, the surge shows that cannabinoid commerce can flourish even where recreational cannabis is banned. Companies must navigate exacting rules, and the framework may evolve. As always, verify current rules before acting. This article is informational, for adults of legal age; verify local legality before acting on it.


